Home / Share Price Target / Glenmark
Glenmark Pharma Share Price Target 2024, 2025, 2026 to 2039 With Charts
Glenmark Pharmaceuticals Limited | |||
 | Symbol: GLENMARK | ||
| Price: ₹1,533.69 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Glenmark Pharma Brief Company Overview
- 1.1: Glenmark Pharmaceuticals: A Global Pharmaceutical Leader
- 1.2: Glenmark Pharma Financial Performance
- 1.2.1: Is Glenmark Pharma A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Glenmark Pharma Share Price Target For 2024
- 2.1.1: Glenmark Pharma Share Price Target Table For 2024
- 2.1.2: Summary: Glenmark Pharma Share Price Prediction For 2024
- 2.2: Glenmark Pharma Share Price Target For 2025
- 2.2.1: Glenmark Pharma Share Price Target Table For 2025
- 2.2.2: Summary: Glenmark Pharma Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Glenmark Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Glenmark Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Glenmark Pharma Past Performance
Glenmark Pharma Brief Company Overview
Glenmark Pharmaceuticals: A Global Pharmaceutical Leader
Established in 1977, Glenmark Pharmaceuticals has emerged as a prominent player in the global pharmaceutical industry. Headquartered in Mumbai, India, the company possesses a substantial market presence across multiple regions, including North America, Latin America, Europe, Japan, and international markets.
Glenmark's diversified product range encompasses both branded and generic formulations, specializing in therapeutic areas such as dermatology, respiratory, and oncology.
- Branded Formulations: Glenmark offers a portfolio of innovative branded products, including Ryaltris nasal spray for seasonal allergic rhinitis.
- Generic Formulations: The company's generic formulations provide affordable access to essential medicines in various therapeutic categories.
- Active Pharmaceutical Ingredients: Glenmark manufactures a range of active pharmaceutical ingredients, serving as a key supplier to the global pharmaceutical market.
Glenmark's commitment to innovation and research is evident in its robust product pipeline, which includes several promising drug candidates in Phase 1 and 2 clinical trials.
The company's reputation for excellence and customer focus has garnered widespread recognition within the pharmaceutical industry, solidifying its position as a reliable and trusted partner in healthcare.
Advertisement
Glenmark Pharma Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 47,026.63 Crore | Market valuation of Glenmark Pharma's shares. |
| Revenue (TTM) | 12,861.21 Crore | Total revenue generated by Glenmark Pharma over the past twelve months. |
| Net Income (TTM) | -1,573.21 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 14.5% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | -10.2% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | -4.6% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +126.9% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 15.68 | Company's total debt divided by total shareholder equity. |
| Total Debt | 1,230.93 Crore | Sum of Glenmark Pharma's current & long-term financial obligations. |
| Total Cash | 1,659.45 Crore | Total amount of liquid funds available to Glenmark Pharma. |
| Beta | 0.88 | Beta is less than 1 indicating that the Glenmark Pharma's price is less volatile than the market. |
Is Glenmark Pharma A Good Buy For Long Term?
Glenmark Pharma (market cap: ₹43,279.17 crore) shows strong past performance (105.10% return in the past 12 months, 210.77% over three years). However, its Q1 2024-25 report reveals a concerning net loss of ₹1,573.21 crore, a -10.2% profit margin, and a recent revenue dip of -4.6%. While holding a cash balance of ₹1,659.45 crore against ₹1,230.93 crore debt, the significant loss warrants caution. Therefore, despite impressive past returns, it's currently an average buy for the long term, requiring close monitoring of future financial performance.
To predict the Glenmark Pharma's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Glenmark Pharma Share Price Target For 2024
The line chart displays the monthly closing prices of Glenmark Pharma with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Glenmark Pharma shares in 2024, see the table below.
Advertisement
Glenmark Pharma Share Price Target Table For 2024
| Glenmark Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 1578.00 (+2.88%) | Fibonacci Extension Level 150% |
| 2024 Target 2 | 1560.00 (+1.71%) | Price Action: Nov 2024 High |
| 2024 Target 1 | 1542.19 (+0.55%) | Custom Fibonacci Extension Lvl 23.6% |
| Current Price | 1533.69 | Glenmark Pharma's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 1531.08 (-0.18%) | Price Action: Chart |
| Stop Loss 2 | 1513.85 (-1.3%) | Fibonacci Retracement Extended 28.2% |
| Stop Loss 3 | 1494.26 (-2.58%) | Fibonacci Retracement Extended 82.6% |
Summary: Glenmark Pharma Share Price Prediction For 2024
In summary, Glenmark Pharma has surged by ₹679.74, achieving a notable +79.60% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Glenmark Pharma for 2024 predicts an additional rise of 0.55% to 2.88% by the end of 2024 with three potential targets T1: 1542.19, T2: 1560.00, T3: 1578.00. Stop Loss at SL1: 1531.08, SL2: 1513.85, SL3: 1494.26.
Glenmark Pharma has a 52-week high of ₹1830.94, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹730.04, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Glenmark Pharma.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Glenmark Pharma Share Price Target For 2025
The line chart displays the monthly closing prices of Glenmark Pharma with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Glenmark Pharma shares in 2025, see the table below.
Advertisement
Glenmark Pharma Share Price Target Table For 2025
| Glenmark Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 2263.95 (+47.61%) | Fibonacci Extension Level 150% |
| 2025 Target 2 | 2222.81 (+44.93%) | Price Action: Chart |
| 2025 Target 1 | 2200.80 (+43.49%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 1533.69 | Glenmark Pharma's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 1289.81 (-15.91%) | Technical Indicator: MA200 |
| Stop Loss 2 | 1276.91 (-16.75%) | Price Action: Chart |
| Stop Loss 3 | 1253.93 (-18.25%) | Price Action: Chart |
Summary: Glenmark Pharma Share Price Prediction For 2025
In summary, Glenmark Pharma has surged by ₹679.74, achieving a notable +79.60% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Glenmark Pharma for 2025 predicts an additional rise of 43.49% to 47.61% by the end of 2025 with three potential targets T1: 2200.80, T2: 2222.81, T3: 2263.95. Stop Loss at SL1: 1289.81, SL2: 1276.91, SL3: 1253.93.
Glenmark Pharma has a All-Time high of ₹1830.94, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹730.04, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Glenmark Pharma, we have created a specific page for that check here: Glenmark Pharma Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Glenmark Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Glenmark Pharma share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 16.24% over the next 15 years.
For complete year by year Glenmark Pharma long term share price target from 2024, 2025 to 2039 check the below table.
Glenmark Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Glenmark Pharma Target | YoY Change % |
|---|---|---|
| 2024 | ₹1,533.69 | [Current Price] |
| 2024 | ₹1,772.62 | 15.57% |
| 2025 | ₹2,747.94 | 55.02% |
| 2026 | ₹3,684.58 | 34.08% |
| 2027 | ₹4,310.62 | 16.99% |
| 2028 | ₹5,159.74 | 19.69% |
| 2029 | ₹5,930.69 | 14.94% |
| 2030 | ₹7,135.47 | 20.31% |
| 2031 | ₹8,143.66 | 14.12% |
| 2032 | ₹8,510.75 | 4.5% |
| 2033 | ₹9,367.28 | 10.06% |
| 2034 | ₹10,088.77 | 7.7% |
| 2035 | ₹11,523 | 14.21% |
| 2036 | ₹12,602.74 | 9.37% |
| 2037 | ₹12,710.88 | 0.85% |
| 2038 | ₹13,574.82 | 6.79% |
| 2039 | ₹14,575.69 | 7.37% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Glenmark Pharma Past Performance
- In 2000, Glenmark Pharma opening price was ₹14.01
- As of Thu 14 Nov 2024 the price stands at ₹1,533.69.
- This represents a Compound Annual Growth Rate (CAGR) of 20.66%.
- In 24 years, an investment of 10,000 would have become ₹10.94 Lakh.
As we wrap up, we hope you like our study on Glenmark Pharma share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Glenmark Pharma Share Price History
- Glenmark Pharma Price Target Tomorrow
- Glenmark Pharma Dividend History
- Glenmark Pharma Bonus History
- Glenmark Pharma Split History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
